Cargando…

Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds

BACKGROUND: Mesenchymal stem cells (MSCs) exert positive effects in chronic wounds. However, critical parameters, such as the most effective administration routes, remain unclear. Accordingly, the purpose of this study was to compare the effects of topical and systemic transplantation MSCs on diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Jianxin, Liang, Jiaji, Cao, Yingxuan, El Akkawi, Mariya M., Liao, Xuan, Chen, Xiaojia, Li, Chengzhi, Li, Kecheng, Xie, Guanghui, Liu, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010295/
https://www.ncbi.nlm.nih.gov/pubmed/33789742
http://dx.doi.org/10.1186/s13287-021-02288-8
_version_ 1783673033007824896
author Yan, Jianxin
Liang, Jiaji
Cao, Yingxuan
El Akkawi, Mariya M.
Liao, Xuan
Chen, Xiaojia
Li, Chengzhi
Li, Kecheng
Xie, Guanghui
Liu, Hongwei
author_facet Yan, Jianxin
Liang, Jiaji
Cao, Yingxuan
El Akkawi, Mariya M.
Liao, Xuan
Chen, Xiaojia
Li, Chengzhi
Li, Kecheng
Xie, Guanghui
Liu, Hongwei
author_sort Yan, Jianxin
collection PubMed
description BACKGROUND: Mesenchymal stem cells (MSCs) exert positive effects in chronic wounds. However, critical parameters, such as the most effective administration routes, remain unclear. Accordingly, the purpose of this study was to compare the effects of topical and systemic transplantation MSCs on diabetic ischemic wound healing and explored the underlying mechanisms. METHOD: A diabetic ischemic wound model was created on the dorsal foot of type 2 diabetes mellitus (T2DM) rat. Bone marrow-derived mesenchymal stem cells (BM-MSCs) were administered via two routes: topical injection and intravenous (IV) infusion. Wound healing outcomes and blood glucose level were assessed dynamically. Meanwhile, blood flow recovery was evaluated in ischemic gastrocnemius muscles. The homing and transdifferentiation of mKate2-labeled BM-MSCs were assessed by fluorescence imaging and immunohistochemistry (IHC) analysis. RESULT: Both topical and systemic treatments had a positive effect on the diabetic ischemic wound showing a significant reduction in wound area at day 14. Histological results showed an increase in the length of epithelial edges, collagen content, microvessel density in the wound bed, and a higher expression of vascular endothelial growth factor (VEGF). Meanwhile, systemic administration can ameliorate hyperglycemia and improve the blood perfusion of the ischemic hindlimb. BM-MSCs administered systemically were found distributed in wounded tissue and transdifferentiated into endothelial cells. Furthermore, BM-MSCs stimulated angiogenesis at wound sites by downregulating phosphatase and tensin homolog (PTEN) and activation of AKT signaling pathway. CONCLUSIONS: The results demonstrated that both transplantation delivery method (topical and systemic) of BM-MSCs accelerated wound healing remarkably under pathological conditions. Nevertheless, systemic administration has the potential to ameliorate hyperglycemia and repair the damaged tissue.
format Online
Article
Text
id pubmed-8010295
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80102952021-03-31 Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds Yan, Jianxin Liang, Jiaji Cao, Yingxuan El Akkawi, Mariya M. Liao, Xuan Chen, Xiaojia Li, Chengzhi Li, Kecheng Xie, Guanghui Liu, Hongwei Stem Cell Res Ther Research BACKGROUND: Mesenchymal stem cells (MSCs) exert positive effects in chronic wounds. However, critical parameters, such as the most effective administration routes, remain unclear. Accordingly, the purpose of this study was to compare the effects of topical and systemic transplantation MSCs on diabetic ischemic wound healing and explored the underlying mechanisms. METHOD: A diabetic ischemic wound model was created on the dorsal foot of type 2 diabetes mellitus (T2DM) rat. Bone marrow-derived mesenchymal stem cells (BM-MSCs) were administered via two routes: topical injection and intravenous (IV) infusion. Wound healing outcomes and blood glucose level were assessed dynamically. Meanwhile, blood flow recovery was evaluated in ischemic gastrocnemius muscles. The homing and transdifferentiation of mKate2-labeled BM-MSCs were assessed by fluorescence imaging and immunohistochemistry (IHC) analysis. RESULT: Both topical and systemic treatments had a positive effect on the diabetic ischemic wound showing a significant reduction in wound area at day 14. Histological results showed an increase in the length of epithelial edges, collagen content, microvessel density in the wound bed, and a higher expression of vascular endothelial growth factor (VEGF). Meanwhile, systemic administration can ameliorate hyperglycemia and improve the blood perfusion of the ischemic hindlimb. BM-MSCs administered systemically were found distributed in wounded tissue and transdifferentiated into endothelial cells. Furthermore, BM-MSCs stimulated angiogenesis at wound sites by downregulating phosphatase and tensin homolog (PTEN) and activation of AKT signaling pathway. CONCLUSIONS: The results demonstrated that both transplantation delivery method (topical and systemic) of BM-MSCs accelerated wound healing remarkably under pathological conditions. Nevertheless, systemic administration has the potential to ameliorate hyperglycemia and repair the damaged tissue. BioMed Central 2021-03-31 /pmc/articles/PMC8010295/ /pubmed/33789742 http://dx.doi.org/10.1186/s13287-021-02288-8 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Yan, Jianxin
Liang, Jiaji
Cao, Yingxuan
El Akkawi, Mariya M.
Liao, Xuan
Chen, Xiaojia
Li, Chengzhi
Li, Kecheng
Xie, Guanghui
Liu, Hongwei
Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
title Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
title_full Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
title_fullStr Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
title_full_unstemmed Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
title_short Efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
title_sort efficacy of topical and systemic transplantation of mesenchymal stem cells in a rat model of diabetic ischemic wounds
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010295/
https://www.ncbi.nlm.nih.gov/pubmed/33789742
http://dx.doi.org/10.1186/s13287-021-02288-8
work_keys_str_mv AT yanjianxin efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT liangjiaji efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT caoyingxuan efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT elakkawimariyam efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT liaoxuan efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT chenxiaojia efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT lichengzhi efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT likecheng efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT xieguanghui efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds
AT liuhongwei efficacyoftopicalandsystemictransplantationofmesenchymalstemcellsinaratmodelofdiabeticischemicwounds